Document is current
Any future updates will be listed below
-
Authors
Delyon, Julie
Becherirat, Selma
Roger, Anissa
Bernard-Cacciarella, Mélanie
Reger De Moura, Coralie
Louveau, Baptiste
Mourah, Samia
Lebbé, Céleste
Dumaz, Nicolas
- License Information
-
More Information
Article History
Received: 25 June 2024
Accepted: 11 November 2024
First Online: 21 November 2024
Declarations
:
: The cohort of patients with unresectable advanced melanoma identified from the French prospective MELBASE biobank at Saint-Louis hospital, Paris, were included (ClinicalTrials.gov identifier: NCT02828202, CPP Ile-de-France XI, number 12027, 2012). All patients had provided written informed consent prior to enrollment. For melanoma cell xenograft experiments, animal housing, handling and all procedures involving mice were performed in accordance to Directive 2010/63/EU and all protocols were approved by the Committee on the Ethics of Animal Experiments of the French Ministry of Agriculture (Permit Number: APAFIS#11775-2017101316112852 v2).
: Not applicable.
: The authors declare no competing interests.
